RecruitingNot Applicable

Recurrent Visceral Leishmaniasis in HIV Co-Infection

Ethiopia20 participantsStarted 2025-10-21

Plain-language summary

The aim is (1) to better understand the underlying causes and predispositions for relapse and parasite persistence in visceral leishmaniasis (VL) patients living with HIV and (2) to improve treatment monitoring of this target group in Ethiopia

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. VL-HIV infection 1.1. VL: microscopically confirmed parasite presence in spleen or bone marrow tissue at first episode or relapse; for known active chronic cases: decision to treat VL 1.2. HIV: confirmed viral infection (new or past)
✓. ≥18 years

Exclusion criteria

✕. Not willing to provide written informed consent
✕. Not willing to adhere to the follow-up visits
✕. Mentally or physically incapable to participate in the study (to the discretion of the treating physician)

What they're measuring

key host and pathogen factors of active chronicity in VL/HIV patients

Timeframe: 12 months

Trial details

NCT IDNCT07487350

SponsorInstitute of Tropical Medicine, Belgium

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2027-04

Contact for this trial

Nicole Berens-Riha

0460850115 nberens@itg.be

View on ClinicalTrials.gov More Hiv trials